Aug 21 (Reuters) - Hamlet BioPharma AB HAMLETb.TE:
HAMLET BIOPHARMA ANNOUNCES COMPLETION OF ALPHA1H PHASE II STUDY IN NON-MUSCLE INVASIVE BLADDER CANCER
HAMLET BIOPHARMA AB: ALL PRIMARY & SECONDARY ENDPOINTS OF SAFETY & EFFICACY WERE REACHED
Further company coverage: [HAMLETb.TE]